Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two‐state and operational models
- 21 June 2013
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 169 (6) , 1189-1202
Abstract
Two‐state and operational models of both agonism and allosterism are compared to identify and characterize common pharmacological parameters. To account for the receptor‐dependent basal response, constitutive receptor activity is considered in the operational models. By arranging two‐state models as the fraction of active receptors and operational models as the fractional response relative to the maximum effect of the system, a one‐by‐one correspondence between parameters is found. The comparative analysis allows a better understanding of complex allosteric interactions. In particular, the inclusion of constitutive receptor activity in the operational model of allosterism allows the characterization of modulators able to lower the basal response of the system; that is, allosteric modulators with negative intrinsic efficacy. Theoretical simulations and overall goodness of fit of the models to simulated data suggest that it is feasible to apply the models to experimental data and constitute one step forward in receptor theory formalism.Linked Articles: Another recent review on allosteric modulation can be found at:Kenakin, T (2013). New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2. British Journal of Pharmacology 168: 554–575. doi: 10.1111/j.1476‐5381.2012.02223.xAnd in this issue of BJP there is an article on a new allosteric modulator:Newman AS, Batis N, Grafton G, Caputo F, Brady CA, Lambert J, Peters JA, Gordon J, Brain KL, Powell AD and Barnes NM (2013). 5‐Chloroindole: a potent allosteric modulator of the 5‐HT3 receptor. British Journal of Pharmacology 169: 1228–1238. doi: 10.1111/bph.12213Keywords
This publication has 41 references indexed in Scilit:
- Biased signalling and allosteric machines: new vistas and challenges for drug discoveryBritish Journal of Pharmacology, 2012
- A Simple Method for Quantifying Functional Selectivity and Agonist BiasACS Chemical Neuroscience, 2012
- A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric ModulationJournal of Biological Chemistry, 2012
- Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug DiscoveryJournal of Medicinal Chemistry, 2011
- Quantifying Ligand Bias at Seven-Transmembrane ReceptorsMolecular Pharmacology, 2011
- Analysis of Agonism and Inverse Agonism in Functional Assays with Constitutive Activity: Estimation of Orthosteric Ligand Affinity Constants for Active and Inactive Receptor StatesThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Quantitative Analysis Reveals Multiple Mechanisms of Allosteric Modulation of the mGlu5 Receptor in Rat AstrogliaMolecular Pharmacology, 2011
- Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug DiscoveryPharmacological Reviews, 2010
- On the application of “a plausible model” of allosteric proteins to the receptor for acetylcholineJournal of Theoretical Biology, 1967
- On the nature of allosteric transitions: A plausible modelJournal of Molecular Biology, 1965